or
forgot password
  • cancer clinical trials in encino, CA

  • A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
    Hematology - Oncology Med Group of San Fernando Valley
    Encino, California 91436
    Sarcoma, Kaposi, HIV Infections
    Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer
    Synergy Hematology/Oncology Medical Associates
    Encino, California 91316
    Lung Cancer
    Efficacy Study of ABR-215050 to Treat Prostate Cancer
    Pacific Clinical Center
    Encino, California 91316
    Prostate Cancer
    A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer
    Site Reference ID/Investigator# 25024
    Encino, California 91436
    Ovarian Cancer
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Urology Specialists of Southern California
    Encino, California 91436-2140
    Advanced Prostate Cancer, Prostatic Neoplasms
    Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
    Site Reference ID/Investigator# 96222
    Encino, California 91436
    Hidradenitis Suppurativa
    A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma
    Hematology - Oncology Med Group of San Fernando Valley
    Encino, California 91436
    Sarcoma, Kaposi, HIV Infections
    Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
    Pacific Clinical Center

    Trial Locations
    Pacific Clinical Center
    Los Angeles Clinical Research Center
    Prostatic Neoplasms
    Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
    Urology Specialist of Southern California - Encino
    Encino, California 91436
    Bladder Neoplasm, Intravesical Drug Administration, Neoplasm Recurrence, Local, Transitional Cell, Carcinoma, Carcinoma in Situ, Mycobacterium